CIK 0001372299
- Non-accelerated filer
- Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 4 Open-market sale Director sold 7,500 shares at $4.07 ($30,525)
- 4 Grant or award Chief Financial Officer acquired 125,534 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 346,540 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3/A Insider 3/A
- 4 Exercise or conversion Director acquired 45,000 shares (option exercise)
- 4 Open-market sale Chief Executive Officer sold 115,000 shares at $5.22 ($600,300)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 145,473 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 115,000 shares at $8.04 ($924,600)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 150,300 shares at $17.32 ($2,603,196)
- 4 Open-market sale Director sold 50,000 shares at an average $15.03 ($751,500)
- 4 Open-market sale Chief Executive Officer sold 115,367 shares at $14.15 ($1,632,443)
- 4 Open-market sale Director sold 63,429 shares at $15.07 ($955,875)
- 4 Open-market sale Director sold 15,000 shares at $15.00 ($225,000)
Page 5 of 15 · 288 filings